One of my problems with this study (and many preliminary medical intervention studies hyped mostly by press releases) is that it deals with a biomarker--telomer

One of my problems with this study (and many preliminary medical intervention studies hyped mostly by press releases) is that it deals with a biomarker--telomere length--rather than with a hard endpoint, for example actual improved cancer survival and reduced all-cause mortality in the patients. Anyone looking on can read the paper for themselves for issues like sample size, the reported statistics, whether the expected finding was specified in advance, and so on. A recent submission to HN[1] cautions that press releases are not usually good guides to what a study has actually found. [1] http://www.sciencebasedmedicine.org/communicating-health-science-news/ http://www.sciencebasedmedicine.org/communicating-health-sci...